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Abstract
© 2017 Charles C. Emene et al. Increased free radical production had been documented in
group A (β-hemolytic) streptococcus infection cases. Comparing 71 erysipelas patients to 55
age-matched healthy individuals, we sought for CAT, SOD1, and SOD2 single polymorphism
mutation (SNPs) interactions with erysipelas' predisposition and serum cytokine levels in the
acute and recovery  phases of  erysipelas  infection.  Whereas female  patients  had a  higher
predisposition to erysipelas, male patients were prone to having a facial localization of the
infection. The presence of SOD1 G7958, SOD2 T2734, and CAT C262 alleles was linked to
erysipelas' predisposition. T and C alleles of SOD2 T2734C individually were linked to patients
with  bullous  and erythematous  erysipelas,  respectively.  G  and A  alleles  of  SOD1 G7958A
individually were associated with lower limbs and higher body part localizations of the infection,
respectively. Serum levels of IL-1β, CCL11, IL-2Rα, CXCL9, TRAIL, PDGF-BB, and CCL4 were
associated with symptoms accompanying the infection, while IL-6, IL-9, IL-10, IL-13, IL-15, IL-17,
G-CSF,  and  VEGF were  associated  with  predisposition  and recurrence  of  erysipelas.  While
variations of IL-1β, IL-7, IL-8, IL-17, CCL5, and HGF were associated with the SOD2 T2734C SNP,
variations of PDFG-BB and CCL2 were associated with the CAT C262T SNP.
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